Ian Stuart Fentiman

Q: What Schools Are Affiliated With Ian Stuart Fentiman

Ian Stuart Fentiman is affiliated with the following schools: King's College London

Ian Stuart Fentiman's AcademicInfluence.com Rankings

Ian Stuart Fentiman

Philosophy

#7680

World Rank

#10925

Historical Rank

Logic

#4721

World Rank

#6045

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Ian Stuart Fentiman's Degrees

PhD Cancer Biology University of Oxford
Bachelors Biochemistry University of Oxford

Why Is Ian Stuart Fentiman Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Ian Stuart Fentiman's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials (2005) (6940)
Tamoxifen for early breast cancer: an overview of the randomised trials (1998) (3764)
Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer (1997) (2362)
Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies (1996) (1205)
Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. (2003) (1056)
Long-Term Results of a Randomized Trial Comparing Breast-Conserving Therapy With Mastectomy: European Organization for Research and Treatment of Cancer 10801 Trial (2000) (914)
Alcohol, tobacco and breast cancer – collaborative reanalysis of individual data from 53 epidemiological studies, including 58 515 women with breast cancer and 95 067 women without the disease (2002) (781)
Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies (2012) (745)
Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853--a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. (2006) (514)
Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial (2010) (504)
Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. (2001) (501)
Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853 (2000) (499)
Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853. (2001) (478)
Randomized clinical trial to assess the value of breast-conserving therapy in stage I and II breast cancer, EORTC 10801 trial. (1992) (444)
Breast conserving therapy versus mastectomy for stage I-II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial. (2012) (442)
Male breast cancer (1998) (377)
Circulating sex hormones and breast cancer risk factors in postmenopausal women: reanalysis of 13 studies (2011) (351)
Quality of life of early-stage breast cancer patients treated with radical mastectomy or breast-conserving procedures: results of EORTC Trial 10801. The European Organization for Research and Treatment of Cancer (EORTC), Breast Cancer Co-operative Group (BCCG). (1998) (343)
Cancer in the elderly: why so badly treated? (1990) (341)
Breast-conserving treatment with or without radiotherapy in ductal carcinoma In Situ: 15-year recurrence rates and outcome after a recurrence, from the EORTC 10853 randomized phase III trial. (2013) (308)
A prospective study of endogenous serum hormone concentrations and breast cancer risk in post-menopausal women on the island of Guernsey. (1997) (299)
The influence on survival of delay in the presentation and treatment of symptomatic breast cancer (1999) (284)
Factors influencing local relapse and survival and results of salvage treatment after breast-conserving therapy in operable breast cancer: EORTC trial 10801, breast conservation compared with mastectomy in TNM stage I and II breast cancer. (1992) (274)
Epstein-Barr virus in epithelial cell tumors: a breast cancer study. (1995) (242)
Re: Reversal of relation between body mass and endogenous estrogen concentrations with menopausal status. (1996) (231)
Dietary fiber and colorectal cancer risk: a nested case-control study using food diaries. (2010) (230)
Prognosis after treatment for loco-regional recurrence after mastectomy or breast conserving therapy in two randomised trials (EORTC 10801 and DBCG-82TM). EORTC Breast Cancer Cooperative Group and the Danish Breast Cancer Cooperative Group. (1999) (212)
Inadequacy of iridium implant as sole radiation treatment for operable breast cancer. (1996) (188)
Do urinary oestrogen metabolites predict breast cancer? Guernsey III cohort follow-up. (1998) (182)
Timing of surgery during menstrual cycle and survival of premenopausal women with operable breast cancer (1991) (174)
Autoantibodies to aberrantly glycosylated MUC1 in early stage breast cancer are associated with a better prognosis (2011) (174)
Inflammation and breast cancer (2013) (173)
PRIMARY HYPOTHYROIDISM ASSOCIATED WITH INTERFERON THERAPY OF BREAST CANCER (1985) (170)
Breast cancer and hormonal contraceptives: further results (1996) (158)
Premenopausal bone loss in the lumbar spine and neck of femur: a study of 225 Caucasian women. (1990) (151)
Mammographic Features and Subsequent Risk of Breast Cancer: A Comparison of Qualitative and Quantitative Evaluations in the Guernsey Prospective Studies (2005) (147)
The axilla: not a no-go zone (1991) (142)
Male breast cancer. (1993) (141)
Stress and relapse of breast cancer. (1989) (138)
Cholera toxin and analogues of cyclic AMP stimulate the growth of cultured human mammary epithelial cells (1980) (129)
Melatonin and breast cancer: a prospective study. (2004) (124)
A comparison of intracavitary talc and tetracycline for the control of pleural effusions secondary to breast cancer. (1986) (121)
A new pathological system for grading DCIS with improved prediction of local recurrence: results from the UKCCCR/ANZ DCIS trial (2010) (119)
Iridium implant treatment without external radiotherapy for operable breast cancer: a pilot study. (1991) (118)
A prospective study of serum insulin-like growth factor-I (IGF-I), IGF-II, IGF-binding protein-3 and breast cancer risk (2005) (117)
Quality of life in breast cancer patients aged over 70 years, participating in the EORTC 10850 randomised clinical trial. (2003) (116)
DOUBLE-BLIND CONTROLLED TRIAL OF TAMOXIFEN THERAPY FOR MASTALGIA (1986) (113)
Proceedings of the International Consensus Conference on Breast Cancer Risk, Genetics, & Risk Management, April, 2007 (2008) (109)
NSAIDs and breast cancer: a possible prevention and treatment strategy (2008) (109)
Treatment of operable breast cancer in the elderly: a randomised clinical trial EORTC 10851 comparing tamoxifen alone with modified radical mastectomy. (2003) (109)
Menopausal symptoms in women with breast cancer: Prevalence and treatment preferences (2004) (107)
Pleural effusion in breast cancer: A review of 105 cases (1981) (106)
Ductal carcinoma in-situ of the breast; second EORTC consensus meeting. (1992) (106)
Adjuvant cyclophosphamide, methotrexate, and fluorouracil in patients with axillary node-positive breast cancer: an update of the Guy's/Manchester trial. (1990) (103)
A prospective study of endogenous serum hormone concentrations and breast cancer risk in premenopausal women on the island of Guernsey. (1997) (102)
Occult axillary lymph node metastases are of no prognostic significance in breast cancer (2002) (101)
Fortnightly Review: Familial breast cancer (1994) (96)
Electropotential measurements as a new diagnostic modality for breast cancer (1998) (96)
Digital infrared thermal imaging (DITI) of breast lesions: sensitivity and specificity of detection of primary breast cancers. (2011) (95)
Different patterns of inflammation and prognosis in invasive carcinoma of the breast (2006) (90)
Evaluation of a group cognitive behavioural intervention for women suffering from menopausal symptoms following breast cancer treatment (2009) (87)
Selective contact-dependent cell communication (1976) (85)
Gamma-glutamyltransferase and risk of cancer in a cohort of 545,460 persons - the Swedish AMORIS study. (2011) (83)
Palliative chemotherapy for advanced or metastatic colorectal cancer. Colorectal Meta-analysis Collaboration. (2000) (83)
Paget's disease of the nipple: A multi-focal manifestation of higher risk disease. (2002) (81)
Effect of menstrual phase on surgical treatment of breast cancer (1994) (77)
IN-SITU BREAST CANCER: THE EORTC CONSENSUS MEETING (1989) (76)
Dosage and duration of tamoxifen treatment for mastalgia: A controlled trial (1988) (76)
Relationship of blood prolactin levels and the risk of subsequent breast cancer. (1992) (74)
Mucoid breast carcinomas: histology and prognosis. (1997) (74)
The permanent effect of reproductive events on blood prolactin levels and its relation to breast cancer risk: a population study of postmenopausal women. (1988) (74)
Consensus conference on breast conservation. (2006) (73)
Can mood disorder in women with breast cancer be identified preoperatively? (1995) (71)
Bone mineral content of women receiving tamoxifen for mastalgia. (1989) (71)
Autoantibodies to the 90kDa heat shock protein and poor survival in breast cancer patients. (1998) (70)
Control of pleural effusions in patients with breast cancer a randomized trial (1983) (70)
A prospective study of obesity, lipids, apolipoproteins and ischaemic heart disease in women. (1992) (69)
Paget disease of the nipple: a multifocal manifestation of higher-risk disease. (2002) (68)
Mastectomy or conservation for early breast cancer: psychological morbidity. (1992) (67)
Meat, poultry and fish and risk of colorectal cancer: pooled analysis of data from the UK dietary cohort consortium (2010) (67)
Characterisation of complete responders to combination chemotherapy for advanced breast cancer: a retrospective EORTC Breast Group study. (1996) (67)
In situ ductal carcinoma of the breast: implications of disease pattern and treatment. (1986) (67)
Survival following local skin recurrence after mastectomy (1985) (67)
A prospective study of urinary oestrogen excretion and breast cancer risk. (1996) (65)
Relationship of mammographic parenchymal patterns with breast cancer risk factors and risk of breast cancer in a prospective study. (1990) (65)
Smoking and prognosis in women with breast cancer (2005) (61)
Autoantibodies to MUC1 glycopeptides cannot be used as a screening assay for early detection of breast, ovarian, lung or pancreatic cancer (2013) (61)
The Insulin-Like Growth Factor System and Mammographic Features in Premenopausal and Postmenopausal Women (2006) (56)
Caesium137 implant as sole radiation therapy for operable breast cancer: a phase II trial (2004) (56)
Life events and breast cancer prognosis. (1992) (56)
The fourth EORTC DCIS Consensus meeting (Château Marquette, Heemskerk, The Netherlands, 23-24 January 1998)--conference report. (1998) (56)
Treatment of breast cancer in older women (2008) (55)
Male breast cancer is not congruent with the female disease. (2016) (53)
Serum prolactin levels in women with breast cancer and their relationship to survival. (1986) (53)
Treatment of operable breast cancer in the elderly: a randomised clinical trial EORTC 10850 comparing modified radical mastectomy with tumorectomy plus tamoxifen. (2003) (53)
The relationship between blood prolactin levels and risk of breast cancer in premenopausal women. (1987) (53)
Breast carcinoma in women age 25 years or less (2002) (51)
A high number of tumor free axillary lymph nodes from patients with lymph node negative breast carcinoma is associated with poor outcome (2002) (51)
Proceedings of the consensus conference on breast conservation, April 28 to May 1, 2005, Milan, Italy (2006) (51)
Pregnancy and menstrual hormone levels in mothers of twins compared to mothers of singletons. (1998) (50)
Determinants of the availability and accuracy of self-reported birth weight in middle-aged and elderly women. (2002) (49)
The endocrine prevention of breast cancer. (1989) (49)
PENSIVE WOMEN, PAINFUL VIGILS: CONSEQUENCES OF DELAY IN ASSESSMENT OF MAMMOGRAPHIC ABNORMALITIES (1988) (48)
The effect of tibolone in postmenopausal women receiving tamoxifen after surgery for breast cancer: a randomised, double‐blind, placebo‐controlled trial (2005) (48)
Identification of genetic variants that influence circulating IGF1 levels: a targeted search strategy. (2008) (48)
Effects of patient selection on the applicability of results from a randomised clinical trial (EORTC 10853) investigating breast-conserving therapy for DCIS (2002) (47)
Urinary androgens and breast cancer risk: results from a long-term prospective study based in Guernsey (2000) (47)
Variations in diagnostic and therapeutic procedures in a multicentre, randomized clinical trial (EORTC 10853) investigating breast-conserving treatment for DCIS. (2001) (47)
Gamma-glutamyl transferase: risk and prognosis of cancer (2012) (45)
Diagnosis and treatment of malignant pleural effusions. (1987) (45)
Assessment of skin dose and its relation to cosmesis in the conservative treatment of early breast cancer. (1988) (45)
Elevated IgG4 in patient circulation is associated with the risk of disease progression in melanoma (2015) (45)
Effect of tamoxifen on oestrogen binding, lipid and lipoprotein concentrations and blood clotting parameters in premenopausal women with breast pain. (1988) (45)
Free estradiol and breast cancer risk in postmenopausal women: comparison of measured and calculated values. (2003) (44)
Are the elderly receiving appropriate treatment for cancer? (1996) (44)
Commission of the European Communities "Europe Against Cancer" Programme. European school of oncology advisory report. Cancer treatment in the elderly. (1993) (44)
Early drain removal following modified radical mastectomy: A randomized trial (1992) (43)
Serum progesterone and prognosis in operable breast cancer. (1996) (42)
Serum progesterone at the time of surgery and survival in women with premenopausal operable breast cancer. (1994) (42)
γ-Glutamyl transferase and breast cancer risk (2010) (42)
Junctional intercellular communication pattern of cultured human breast cancer cells. (1979) (41)
Epidemiology and endocrinology of benign breast disease (2005) (40)
Risk factors for regional nodal relapse in breast cancer patients with one to three positive axillary nodes. (2012) (40)
A prospective study of serum bile acid concentrations and colorectal cancer risk in post-menopausal women on the island of Guernsey (2002) (39)
A controlled trial of short-term versus standard axillary drainage after axillary clearance and iridium implant treatment of early breast cancer. (1991) (39)
The Role of NSAIDs in Breast Cancer Prevention and Relapse: Current Evidence and Future Perspectives (2016) (39)
Fixed and modifiable risk factors for breast cancer. (2001) (39)
Prognosis of metachronous contralateral breast cancer: importance of stage, age and interval time between the two diagnoses (2011) (37)
Breast cancer prevention: present and future. (2001) (36)
Long-term follow-up of the first breast conservation trial: Guy' wide excision study. (2000) (36)
Breast compliance: A new method for evaluation of cosmetic outcome after conservative treatment of early breast cancer (1990) (35)
The interaction of oestrogen receptor status and pathological features with adjuvant treatment in relation to survival in patients with operable breast cancer: a retrospective study of 2660 patients. (2004) (34)
Gigantomastia: A problem of local recurrence. (2006) (34)
LHRH analogue for treatment of recurrent and refractory mastalgia. (1990) (34)
The significance of supraclavicular fossa node recurrence after radical mastectomy (1986) (34)
Electropotential evaluation as a new technique for diagnosing breast lesions. (1997) (33)
Which patients are cured of breast cancer? (1984) (33)
Tamoxifen protects against steroid-induced bone loss. (1992) (33)
Intake of dietary fats and colorectal cancer risk: prospective findings from the UK Dietary Cohort Consortium. (2010) (32)
ZEN and the art of breast health maintenance (2012) (32)
Cultured human breast cancer cells lose selectivity in direct intercellular communication (1977) (31)
Comparison of the surgical procedures for breast conserving treatment of early breast cancer in seven EORTC centres. (1996) (30)
Risk factors for metachronous contralateral breast cancer suggest two aetiological pathways. (2009) (29)
Serum prolactin levels and their relationship to survival in women with operable breast cancer. (1995) (29)
Third meeting of the DCIS Working Party of the EORTC (Fondazione Cini, Isola S. Giorgio, Venezia, 28 February 1994)--Conference report. (1994) (29)
Alcohol intake and risk of colorectal cancer: Results from the UK Dietary Cohort Consortium (2010) (29)
Insight into the treatment of cancer in older patients: developments in the last decade. (2006) (29)
Basal Phenotype Breast Cancer: Implications for Treatment and Prognosis (2011) (29)
Prognosis of synchronous bilateral breast cancer (2009) (28)
The association of height, weight, menstrual and reproductive events with breast cancer: results from two prospective studies on the island of Guernsey (United Kingdom) (1993) (28)
Surgical options for male breast cancer (2018) (28)
Treatment of cancer in the elderly. (1991) (28)
Proceedings of the International Consensus Conference on Breast Cancer Risk, Genetics, & Risk Management, April, 2007 (2009) (27)
Family history of breast cancer and its association with disease severity and mortality (2016) (26)
WHO NEEDS STEROID RECEPTOR ASSAYS? (1989) (26)
Follow-up of patients with aspirated breast cysts is necessary. (1989) (26)
A trial of human alpha interferon as an adjuvant agent in breast cancer after loco-regional recurrence. (1987) (26)
Communication with Older Breast Cancer Patients (2007) (26)
Survival of premenopausal breast carcinoma patients in relation to menstrual cycle timing of surgery and estrogen receptor/progesterone receptor status of the primary tumor (1999) (25)
Diagnosis of breast cancer in young women. (1991) (25)
Detection and Treatment of Early Breast Cancer (1991) (25)
Age as prognostic factor in premenopausal breast cancer (1993) (23)
8. The dilemma of in situ carcinoma of the breast. (2001) (23)
Bone density of normal women in relation to endogenous and exogenous oestrogens. (1994) (22)
Prognosis of patients with breast cancers up to 1 cm in diameter. (1996) (22)
Psychosocial adjustment of women with mastalgia (1995) (22)
The biology of male breast cancer. (2018) (22)
The impact of the Occupation of Guernsey 1940–1945 on breast cancer risk factors and incidence (2007) (21)
Surgery for cancer in the elderly (1997) (21)
Caesium(137) implant as sole radiation therapy for operable breast cancer: a phase II trial. (2004) (20)
What can be done about hot flushes after treatment for breast cancer? (2010) (20)
Value of needle biopsy in outpatient diagnosis of breast cancer. (1980) (19)
Biology and treatment of ductal carcinoma in situ (2007) (18)
Angiosarcoma of the skin overlying an irradiated breast (1991) (18)
Automatic needle biopsy in the diagnosis of early breast cancer. (1991) (18)
Radioimmunoassayable insulin-like growth factor-I in human breast cyst fluid. (1989) (18)
Breast duct microendoscopy in nipple discharge: microbrush improves cytology (2005) (18)
Radiofrequency ablation in the treatment of primary breast cancer: no surgical redundancies yet (2008) (18)
Salivary oestradiol and progesterone levels in premenopausal women with breast cancer. (1986) (18)
Factors at presentation influencing the prognosis in breast cancer. (1989) (17)
Sensory changes after treatment of operable breast cancer (2005) (17)
Reasons for non-entry of patients with DCIS of the breast into a randomised trial (EORTC 10853). (1991) (17)
Long-term follow-up of the first breast conservation trial (Guy's Wide Excision Study) (1998) (16)
Systemic Lupus Erythematosus and Breast Cancer (2008) (16)
The treatment of in situ breast cancer. (1989) (16)
Adjuvant Therapy in Stage I Carcinoma of the Breast: The Influence of Multigene Analyses and Molecular Phenotyping (2012) (16)
Cytochrome P450dbl phenotypes in malignant and benign breast disease. (1990) (16)
Treatment of Mammary Duct Fistula by Fistulectomy and Saucerization (2005) (15)
Patterns of metastasis in women with metachronous contralateral breast cancer (2012) (15)
Consensus Conference on Breast Conservation, Milan, Italy, April 28–May 1, 2005 (2006) (15)
The binding of blood-borne estrogens in normal vegetarian and omnivorous women and the risk of breast cancer. (1988) (15)
Which Patients Need an Axillary Clearance after Sentinel Node Biopsy? (2011) (15)
Proceedings of the consensus conference on breast conservation, Milan, Italy, April 28-May 1, 2005. (2006) (15)
Is routine axillary nodal dissection necessary in the treatment of breast cancer? (1996) (15)
Progression of breast cancer following locoregional ipsilateral recurrence: importance of interval time (2015) (15)
Cyclical tumour variations in premenopausal women with early breast cancer. (1995) (14)
Goserelin (Zoladex) and the skeleton (1994) (14)
Prophylactic mastectomy: deliverance or delusion? (1998) (14)
Long-term effects of tibolone on mammographic density. (2004) (14)
Cancer in the elderly : treatment and research (1994) (14)
Paget disease of the nipple (13)
BREAST CANCER, TAMOXIFEN, AND SURGERY (1988) (13)
Breast reconstruction (2006) (13)
The hormonal milieu and prognosis in operable breast cancer. (1993) (13)
Ductal in situ Component and Prognosis in Invasive Mammary Carcinoma (2004) (13)
FINE NEEDLE ASPIRATION CYTOLOGY OF PALPABLE BREAST LESIONS (1992) (13)
Unmet needs of men with breast cancer. (2018) (12)
Applied kinesiology for treatment of women with mastalgia. (2001) (12)
Axillary dissection in breast cancer (1991) (12)
Breast cancer prevention with tamoxifen. The role of tamoxifen in the prevention of breast cancer. (1990) (12)
Two week wait for suspected cancer: milestone or millstone? (2005) (12)
Urinary Estrogen Metabolites and Breast Cancer: A Combined Analysis of Individual Level Data (2013) (12)
Body weight and vascular invasion in post-menopausal women with breast cancer. (1997) (12)
When is a completion axillary lymph node dissection necessary in the presence of a positive sentinel lymph node? (2014) (12)
Beneficial Effect of Tamoxifen for Women with DCIS: Long-Term Results from the UK/ANZ DCIS Trial in Women with Locally Excised DCIS. (2009) (12)
The endocrinology of male breast cancer. (2018) (12)
Pathogenesis of breast carcinoma (2004) (11)
Factors influencing loco-regional relapse in older breast cancer patients treated with tumour resection and tamoxifen. (2011) (11)
Studies of tamoxifen in women with mastalgia. (1989) (11)
The sentinel node negative axilla: is it a no-go zone? (2002) (10)
Cyclic AMP inhibits the growth of human breast cancer cells in defined medium. (1984) (10)
Recent developments in the study of benign breast disease. (1993) (10)
PAGET'S DISEASE OF THE NIPPLE (1937) (10)
Should adjuvant chemotherapy be used to treat breast cancer in elderly patients (> or = 70 years of age)? (1997) (10)
Better treatment for breast cancer in older patients (2009) (10)
Ductal carcinoma in situ (DCIS) of the breast--a therapeutic dilemma. (1987) (9)
Prognostic and Predictive Value of HER2 Expression in Ductal Carcinoma In Situ: Results from the UK/ANZ DCIS Randomized Trial (2021) (9)
The influence of premenopausal hormones on severity of climacteric symptoms and use of HRT (2006) (9)
Quality assurance of surgery in clinical trials. (1994) (9)
Peri-operative hormones and prognosis in breast cancer. (1994) (9)
Epidermal Growth Factor and Insulinlike Growth Factor‐I in Human Breast Cyst Fluid (1990) (8)
Influence of radiotherapy on the dose of adjuvant chemotherapy in early breast cancer (1989) (8)
Local recurrence after breast conservation treatment: outcome following salvage mastectomy (1998) (8)
Optimal timing of initial breast cancer surgery. (1992) (8)
Breast cancer risk is positively associated with height (1997) (8)
Paget's Disease of the Nipple (2009) (8)
Hormone dependency of breast tumours developing in the Guernsey Cohort Study (2006) (8)
Breast reconstruction: àla carte not table d'hote. (2012) (7)
Trials of treatment for non-invasive breast cancer. (1998) (7)
Breast cancer and osteoporosis--a bridge at last. (1993) (7)
Management of operable breast cancer in older women (2013) (7)
Axillary node dissection in breast cancer (1992) (7)
Adjuvant androgen treatment of operable breast cancer--a 20 year analysis. (1987) (7)
Conservative treatment of early breast cancer. (1986) (7)
Managing Male Mammary Maladies. (2018) (7)
A controlled trial of adjuvant tamoxifen, with or without prednisolone, in post-menopausal women with operable breast cancer. (1994) (7)
Effective treatment of malignant pleural effusions. (1987) (7)
Medico-legal Aspects of Delay in Diagnosis of Breast Cancer (2017) (6)
Tamoxifen and mastalgia. An emerging indication. (1986) (6)
The Role of Non-Steroidal Anti-Inflammatory Drugs in the Chemoprevention of Breast Cancer (2010) (6)
Growth factor and electrolyte concentration in human breast cyst fluid. (1990) (6)
Assessment of breast problems. (2001) (6)
Surgery in the management of early breast cancer: a review. (1988) (6)
Toremifene, a new agent for treatment of mastalgia: an open study. (2004) (6)
Is axillary clearance the standard of care for breast cancer patients with sentinel node involvement? (2006) (5)
Hibernoma of the thigh. (1975) (5)
A prospective randomized study of two gauges of Biopty-cut needle in diagnosis of early breast cancer (1995) (5)
Improving the outcome for older women with breast cancer (2004) (5)
The role of radiotherapy in breast conserving treatment of ductal carcinoma in situ (DCIS): First results of EORTC trial 10853 (1998) (5)
Social, biological and reproductive characteristics of mothers of twins: implications for breast cancer risk. (1998) (5)
RADIOSENSITIVITY OF IN-SITU CARCINOMA OF THE BREAST (1985) (5)
Adenoma of the nipple: a diagnostic dilemma. (1993) (5)
Adjuvant therapy in stage I carcinoma of the breast (2012) (5)
Position paper by the UKCCCR Elderly Cancer Patients in Clinical Trials Working Group (1999) (5)
Prospects for the prevention of breast cancer. (1992) (5)
Axillary surgery in breast cancer: what debate? (1993) (5)
Diurnal variations in prolactin and growth hormone levels in normal premenopausal vegetarian and omnivorous women. (1986) (5)
Ductal carcinoma in situ. (1992) (5)
Future prospects for the prevention and cure of breast cancer. (2000) (5)
Benign breast disease. (2001) (4)
Prognostic Value of ER and PgR Expression and the Impact of Multi-clonal Expression for Recurrence in Ductal Carcinoma in situ: Results from the UK/ANZ DCIS Trial (2021) (4)
After 65, cancer has a different impact on life expectancy in men and women. (1991) (4)
Sentinel node biopsy in breast cancer. Value is already proved. (1999) (4)
Pathology of breast carcinoma (2004) (4)
Monoclonal antibody HMFG-2 retains activity in vivo and binds to high molecular weight components expressed by metastatic breast cancers. (1986) (4)
Large operable breast cancer: the applicability of primary chemotherapy (1997) (4)
Effect of a GnRH analogue on bone mass in premenopausal patients with mastalgia (1993) (4)
Stress and relapse of breast cancer: Authors' reply (1989) (4)
Endocrine Therapy for Male Breast Cancer (2013) (4)
Male breast cancer: a neglected disease (2019) (4)
Long‐Term Results of Breast Conservation in Chinese Women with Breast Cancer (2009) (4)
Challenges in breast cancer (1999) (4)
Pathological Nipple Discharge (2014) (4)
The defence for the U.K. DCIS Trial. (1993) (4)
TREATMENT OF ELDERLY CANCER PATIENTS: A PLANET IN EVOLUTION (2006) (4)
Synchronous bilateral breast cancer in a patient with Klinefelter’s syndrome (2009) (4)
How do endogenous oestrogens affect breast cancer? (2002) (4)
Progression of breast cancer following locoregional ipsilateral recurrence: importance of interval time (2016) (3)
Cell communication in breast cancer. (1980) (3)
Treatment of screen detected ductal carcinoma in situ: a silver lining within a grey cloud? (1990) (3)
OPTIMAL TIMING OF INITIAL BREAST CANCER SURGERY. REPLY (1992) (3)
Steroid hormones in lymph and blood from women with early breast cancer. (1991) (3)
TAMOXIFEN FOR MASTALGIA (1986) (3)
Breast duct microendoscopy in nipple discharge (2005) (3)
Clinical assessment of patients with mastalgia. (1989) (3)
Axillary surgery in breast cancer--is there still a debate? (1992) (3)
Tamoxifen and Mastalgia (1986) (3)
Current Controversies in Cancer Should Adjuvant Chemotherapy be used to Treat Breast Cancer in Elderly Patients (2 70 years of age) (1997) (3)
Breast problems in general practice: a time for re-assessment. (1999) (2)
Quality control in breast cancer treatment: what information can the surgeon provide? (1991) (2)
Abstract P3-07-02: Prognostic and predictive relevance of HER2 status in ductal carcinomain situ: Results from the UK/ANZ DCIS trial (2016) (2)
Bilateral Inflammatory Pseudotumour of the Breast: A Case Report and Review of the Literature. (2018) (2)
Axillary nodal involvement and parity in breast cancer patients (2005) (2)
Breast conservation techniques for early breast cancer. (1989) (2)
217 Adjuvant Radiotherapy After Breast-conserving Surgery for Ductal Carcinoma in Situ – Fifteen-year Results of the EORTC Randomized Phase III Trial 10853 (2012) (2)
The role of mammography in the diagnosis of breast cancer in women aged 35-40 (1991) (2)
Ductal carcinoma in situ of the breast. (1992) (2)
Psychological sequelae of screening women with a family history of breast cancer. (1998) (2)
A Long Breast Cancer Remission without Standard Therapy (2015) (2)
Breast duct micro-endoscopy does not diagnose pre-invasive malignancy (2004) (2)
Perioperative Endocrine Status and Prognosis in Early Breast Cancer (2006) (2)
Breast cysts: a cause for rejoicing or concern? (2007) (2)
Breast cancer surgery: not for the occasional operator (2005) (2)
Multidisciplinary Atlas of Breast Surgery (1998) (2)
Surgical options for the treatment of operable breast cancer. (1985) (1)
Commission of the European Communities “Europe Against Cancer” Programme. European school of oncology advisory report. Cancer treatment in the elderly.: 25 (1994) (1)
Height and breast cancer risk--the bias of self-reported versus measured results. Comments on height and breast cancer risk, Tavani et al., Eur J Cancer 1998, 34, 543-547. (1999) (1)
Histopathological correlates of breast electropotential measurements (1997) (1)
Operative risk assessment. (1998) (1)
Axillary dissection in breast cancer (1991) (1)
Smoking cessation before surgery: not worth a light? (2010) (1)
Optimising adjuvant endocrine treatment of breast cancer with aromatase inhibitors (2006) (1)
THE MANAGEMENT OF EARLY BREAST CANCER (1960) (1)
Breast cancer management. 2. Benign breast disease (2001) (1)
Prevention of breast cancer (1993) (1)
[Breast cancer treatment]. (2005) (1)
Litigation and doctor-patient communication (2003) (1)
Ductal Carcinoma in Situ Treatment Requires a Multidisciplinary Approach (2013) (1)
How should we approach comprehensive cancer care for elderly people (1997) (1)
Juxtapositional regions of human breast epithelium and fibroblasts in vitro. (1982) (1)
Perioperative Progesterone for Obese Women with Breast Cancer May Improve Survival (2016) (1)
211 Phase III Trial (EORTC 10801) Comparing Breast-conserving Therapy with Radical Mastectomy – Twenty Year Follow-up Results (2012) (1)
Lessons learned in breast cancer surgery (2014) (1)
0-105. Electropotential measurements as a new modality for breast cancer diagnosis: results from a prospective multicentre trial (1997) (1)
Insulin-Like (IGF-I, IGF-II), Epidermal (EGF) and Alpha Transforming (TGF-α) Growth Factors in Human Breast Cyst Fluid (BCF) (1993) (1)
92134257 Relationship of blood prolactin levels and the risk of subsequent breast cancer (1992) (1)
γ-glutamyl transferase and risk of breast cancer (2012) (1)
Serum cotinine and prognosis in breast cancer (2012) (1)
Male breast cancer. (1998) (1)
Abstract P1-09-06: Prognostic and predictive relevance of cell cycle progression (CCP) score in ductal carcinoma in situ: Results from the UK/ANZ DCIS trial (2017) (1)
Treatment of Advanced Disease (2017) (1)
Diagnosis and treatment of male breast cancer (2012) (1)
Hormone Replacement Therapy and Breast Cancer: Proceed with Caution (1995) (1)
Prognostic difficulties of men with breast cancer (2021) (1)
Nil-8 conditioned medium stimulates growth of human mammary epithelial cells (2005) (1)
Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ - Reply (2003) (1)
Erratum to “Intake of dietary fats and colorectal cancer risk: Prospective findings from the UK Dietary Cohort Consortium” [Cancer Epidemiol. 34 (2010) 562–567] (2011) (1)
Who finds breast lumps? (2010) (0)
PATIENTS, PUBLICITY, AND SURGICAL CONTROVERSY. REPLY (1991) (0)
Generic prescribing. (1986) (0)
Breast-conserving treatment for ductal carcinoma in situ; analysis of EORTC trial 10853 (2000) (0)
OC-0134 LOCAL EXCISION WITH OR WITHOUT RADIOTHERAPY IN DUCTAL CARCINOMA IN SITU: TREATMENT AND PROGNOSIS AFTER A RECURRENCE (2012) (0)
BREAST CANCER SCREENING (1988) (0)
Stress and relapse of breast cancer: Authors' reply (1989) (0)
Adjuvant radiotherapy for DCIS - Authors' reply (2000) (0)
Should full axillary clearance be the standard procedure in node positive axilla (2006) (0)
Breast cancer. (1993) (0)
Ductal carcinoma in situ of the breast: Do we still need trials? (1992) (0)
Scleroderma and Breast Cancer (2011) (0)
Occult primary breast cancer (2006) (0)
Breast cancer management. 1. Assessment of breast problems (2001) (0)
26 Scleroderma and Breast Cancer (2017) (0)
Ultrasound should be intrinsic, not optional, in assessment of breast lesions (2009) (0)
Breast duct micro-endoscopy: A study into the fesibility and technique (2002) (0)
Is completion axillary lymph node dissection necessary in the presence of metastasis in the sentinel lymph node (2013) (0)
Quality assurance in breast conserving surgery (1993) (0)
Screen detected breast cancer: is preoperative staging necessary? (2006) (0)
Problems of conservation treatment for breast cancer. (1989) (0)
What is the future for NSAIDS in preventing breast cancer in older women (2008) (0)
The epidemiology of HER-2 positive tumours (2006) (0)
A controlled trial ofadjuvant tamoxifen, with orwithout prednisolone, in post-menopausal women withoperable breast cancer (1994) (0)
Therapeutic focus (1988) (0)
Author's reply: Lessons learned in breast cancer surgery (Br J Surg 2014; 101: 145–147) (2014) (0)
Response from I.S. Fentiman and D. Tong (1997) (0)
Which patients with ductal carcinoma in situ will benefit from sentinel node biopsy? (2008) (0)
The problem of ductal carcinoma in situ of the breast. (1992) (0)
New approaches to operable breast cancer in older women. (2004) (0)
Local-regional management issues in the elderly (2003) (0)
Diagnosis of Breast Cancer (1997) (0)
Atlas of Breast Examination (1997) (0)
Breast cancer treatment. (1995) (0)
Ascites in breast cancer. (1983) (0)
Histology, oestrogen and progesterone receptor status in breast tumours from BRCA1 mutation carriers. (2002) (0)
Variationss in diagnostic and therapeutic proceduress in a multicentre randomised clinical triall (EORTC 10853) investigating breast- conservingg treatment for DCIS (2008) (0)
Endocrine effects of tamoxifen treatment for elderly women with operable breast cancer (1992) (0)
Routine mammograms in symptomatic women <50 yrs with normal physical examination: Is it justified? (2004) (0)
Catamenial pneumothorax mimicking cyclical mastalgia (1993) (0)
Combined therapies and future directions (2011) (0)
Supplementary Material for: The Role of NSAIDs in Breast Cancer Prevention and Relapse: Current Evidence and Future Perspectives (2016) (0)
Comprar Neurological Investigations | Ian S. Fentiman | 9780727910806 | Wiley (2009) (0)
Training of surgeons in oncology--a personal view. (1990) (0)
Clinical Features and Diagnosis (2017) (0)
Which patients are cured of breast cancer? (1984) (0)
Cholecystohepatic Serendipity (1975) (0)
Paget's disease of the nipple: is breast conserving surgery an appropriate treatment? (2002) (0)
Experience with the transversal lower rectus abdomini myocutaneous flap–A new method in breast reconstruction (1986) (0)
Breast cancer chemoprevention: additional observations. Authors' reply (2003) (0)
Tailored Surgery for Older Women with Breast Cancer (2006) (0)
Book Review (1999) (0)
Abstract P3-07-01: Prognostic role and impact of multi-clonal ER and PgR expression in ductal carcinomain situ: Results from the UK/ANZ DCIS trial: (2016) (0)
Advances in Brief Epstein-Barr Virus in Epithelial Cell Tumors : A Breast Cancer Study 1 (2006) (0)
Tamoxifen: use in benign conditions. (1988) (0)
Getting the right balance in treatment of ductal carcinoma in situ(DCIS) (2013) (0)
Plastic and Reconstructive Breast SurgeryIt was the best of times, it was the worst of times. Springer, Berlin (1991), 182 pp, (A Tale of Two Cities, Charles Dickens), (A Tale of Two Cities, Charles Dickens), ISBN: 3-540-52868-7 (1992) (0)
Comprar Challenges in Breast Cancer | Caroline J. Böhme | 9780632052424 | Wiley (2009) (0)
Fistulectomy with saucerisation as treatment for mammary fistula (1997) (0)
Histopathology of benign breast lesions. (1988) (0)
Impact of clear margins invasive breast cancer on local recurrence in breast conserving surgery (2009) (0)
Determining the prognosis of women with synchronous bilateral breast cancer (2007) (0)
"Overweight postmenopausal women have a worse prognosis, partly because nodal positivity is associated with obesity." (2016) (0)
Why follow up breast cancer patients? (2013) (0)
HRT for those at high risk of developing breast cancer: Is it safe? A case-control study (1999) (0)
Erratum to: Meat, poultry and fish and risk of colorectal cancer: pooled analysis of data from the UK dietary cohort consortium (2011) (0)
Nonsteroidal Anti-Inflammatory Drugs and Prevention of Breast Cancer (2008) (0)
Abstract A009: IgG4: a new tool to predict the risk of disease progression in melanoma (2016) (0)
Endorine effecis of tamoxifen treatment in elderly women with early breast cancer (1987) (0)
Erratum: Meat, poultry and fish and risk of colorectal cancer: Pooled analysis of data from the UK dietary cohort consortium (Cancer Causes Control (2010) 21 (1417-1425)) DOI 10.1007/s10552-010-9569-7) (2011) (0)
The treatment of operable breast cancer. (1988) (0)
Breast conserving therapy: workshop report. (1992) (0)
Methylation status of p16 in breast cancer cell lines, normal breast tissue, breast tumours and lymphocytes (2000) (0)
Plastic and Reconstructive Breast Surgery, G. Lemperle, J. Nievergelt, in: It was the best of times, it was the worst of times. Springer, Berlin (1991), A Tale of Two Cities, , Charles Dickens), ISBN: 3-540-52868-7 (1992) (0)
The clinical and prognostic implications of isolated supraclavicular fossa recurrence (2004) (0)
Ductal Carcinoma In Situ of the Breast: One Reason for Considering Radiotherapy as Part of Breast-Conservation Therapy (2008) (0)
SY-6-1 Treatment of operable breast cancer in the elderly (1996) (0)
Patients, publicity, and surgical controversy (1991) (0)
93. Local excision with or without radiotherapy in ductal carcinoma in situ – Treatment and prognosis after a recurrence (2012) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Ian Stuart Fentiman?

Ian Stuart Fentiman is affiliated with the following schools:

King's College London